Articles related to Neurology

In this feature from the British Medical Journal (BMJ), associate editor Peter Doshi explores the emerging research on immunological responses to COVID-19. Is it true that the human population had no pre-existing immunity to SARS-CoV-2? The article attempts to answer this question with a deeper discussion around herd immunity, T cells, antibodies, and more.

In this “How I Treat” feature from Blood, the authors conclude with three representative cases to both illustrate the application of the outlined diagnostic schema and discuss common management considerations, specifically the selection of anticoagulation vs. antiplatelet therapy for secondary prevention.

According to an international task force at the virtual PAINWeek meeting, chronic pain patients can be treated with medical cannabis following one of three protocols based on patient characteristics. The recommendations are timely considering the limited clinician knowledge about medical cannabis treatment and the opioid crisis.

Our friends at the Mayo Clinic have provided this excellent resource to track the data you need to help protect yourself, your patients, your friends, your family, and anyone else you may come in contact with during this unprecedented time. Trends for the US are simple to access and see, whether they are new cases, positive taste rates, total new cases, or others.

In this opinion piece from MedPage Today, the authors state “anti-psychiatry” was “formerly a healthy corrective, but the movement now distracts from real problems and actively hurts people, existing as a disorganized entity outside of mainstream medicine, largely propagated on social media and in non-peer-reviewed sources…that evade scientific dialogue and critique.”

The NCI sponsors and funds the consortium, a multidisciplinary cooperative research organization devoted to the study of correlative tumor biology and new therapies for children with primary central nervous system tumors. New members are chosen through a competitive process based on several characteristics, including clinical trial infrastructure and expertise in basic and translational science.